Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

SHA:688393 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.68	95.15	67.68	90.91	217.68	635.27
Trading Asset Securities	238.51	55.33	52.56	175.54	419.42	210.46
Cash & Short-Term Investments	264.19	150.48	120.25	266.45	637.1	845.73
Cash Growth	140.06%	25.14%	-54.87%	-58.18%	-24.67%	395.81%
Accounts Receivable	189.45	242.84	245.25	239.03	211.94	185.47
Other Receivables	3.83	4.37	4.26	4.19	4.06	1.67
Receivables	193.28	247.21	249.51	243.22	216.01	187.14
Inventory	89.96	84.44	74.97	63.07	40.57	25.05
Prepaid Expenses	-	2.54	1.93	2.12	3.99	0.29
Other Current Assets	100.32	207.58	120.92	20.22	11.51	4.71
Total Current Assets	647.75	692.25	567.57	595.08	909.17	1,063
Property, Plant & Equipment	279.8	298.53	314.38	327.04	276.65	193.76
Long-Term Investments	241.23	241.91	402.48	373.52	86.07	7.5
Goodwill	26.46	26.46	26.46	29.52	29.52	8.09
Other Intangible Assets	10.17	5.58	6.47	5.78	5.85	5.77
Long-Term Deferred Tax Assets	42.93	35.63	27.61	19.04	12.69	12.38
Long-Term Deferred Charges	40.74	40.55	32.37	15.75	4.17	1.83
Other Long-Term Assets	22.94	21.81	22.59	27.06	41.56	-
Total Assets	1,312	1,363	1,400	1,393	1,366	1,292
Accounts Payable	28.53	32.68	37.14	32.59	49.76	55.89
Accrued Expenses	10.68	29.39	30.63	34.31	28.14	18.77
Short-Term Debt	11.3	7.3	21.2	14.3	7	-
Current Portion of Leases	1.98	1.49	2	3.26	2.54	-
Current Income Taxes Payable	5.95	0.88	3.02	2.1	2.11	5.92
Current Unearned Revenue	5.29	6.32	6.82	12.72	8.32	3.97
Other Current Liabilities	7.83	6.44	9.52	14.99	8.97	2.86
Total Current Liabilities	71.56	84.51	110.33	114.26	106.84	87.41
Long-Term Leases	1.02	1.65	5.18	7.24	2.85	-
Long-Term Unearned Revenue	26.97	27.54	28.19	28.94	29.89	30
Long-Term Deferred Tax Liabilities	12.18	13.37	14	16.08	13.34	7.26
Other Long-Term Liabilities	1.58	3.92	3.92	3.92	3.04	-
Total Liabilities	113.31	130.99	161.63	170.45	155.96	124.67
Common Stock	93.57	93.57	93.57	93.34	93.34	93.34
Additional Paid-In Capital	724.44	734.14	749.14	741.35	733.87	751.48
Retained Earnings	408.03	428.16	420.9	394.29	376.79	323.15
Comprehensive Income & Other	-0.11	-0.12	-	-0.38	-	-
Total Common Equity	1,226	1,256	1,264	1,229	1,204	1,168
Minority Interest	-27.22	-24	-25.31	-6.27	5.72	-0.39
Shareholders' Equity	1,199	1,232	1,238	1,222	1,210	1,168
Total Liabilities & Equity	1,312	1,363	1,400	1,393	1,366	1,292
Total Debt	14.29	10.44	28.39	24.8	12.39	-
Net Cash (Debt)	249.89	140.04	91.86	241.64	624.71	845.73
Net Cash Growth	156.90%	52.45%	-61.99%	-61.32%	-26.13%	395.81%
Net Cash Per Share	2.76	1.51	0.96	2.55	6.66	10.88
Filing Date Shares Outstanding	93.57	93.57	93.57	93.34	93.34	93.34
Total Common Shares Outstanding	93.57	93.57	93.57	93.34	93.34	93.34
Working Capital	576.19	607.74	457.23	480.81	802.34	975.5
Book Value Per Share	13.10	13.42	13.50	13.16	12.90	12.51
Tangible Book Value	1,189	1,224	1,231	1,193	1,169	1,154
Tangible Book Value Per Share	12.71	13.08	13.15	12.78	12.52	12.36
Buildings	-	256.64	256.58	238.97	216.44	43.62
Machinery	-	168.4	151.86	141.86	116.01	71.6
Construction In Progress	-	0.74	0.19	10.56	10.99	139.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.